AbbVie Review - Search Videos

AbbVie is the preeminent large-cap name in biotech, says Piper Sandler's Raymond

AbbVie is the preeminent large-cap name in biotech, says Piper Sandler's Raymond

Christopher Raymond, Piper Sander senior biotech analyst, joins 'Power Lunch' to discuss what it means for biotech companies to be defensive, Raymond's thoughts around Abbvie and if biotech companies have hit a bottom.

CNBCJun 6, 2022

AbbVie Products

Understanding Eczema in 60 Seconds

Understanding Eczema in 60 Seconds

1.7M viewsJan 25, 2023

AbbVie in Eye Care

AbbVie in Eye Care

479 viewsJun 5, 2023

AbbVie acquiring Cerevel Therapeutics in $8.7B deal

AbbVie acquiring Cerevel Therapeutics in $8.7B deal

YahooYahoo Finance Video

Top videos

AbbVie | LinkedIn

AbbVie | LinkedIn

Today, Kelly explains how AbbVie provides doctors with the most up-to-date data to assist in patient care. #tinymic #medtok #healthtok #RheumaticAwareness #RheumatoidArthritis #Rheumatology #AskIzzySeries

Today, Kelly explains how AbbVie provides doctors with the most up-to-date data to assist in patient care. #tinymic #medtok #healthtok #RheumaticAwareness #RheumatoidArthritis #Rheumatology #AskIzzySeries

2.3K viewsJan 3, 2024

Abbvie Buys Cancer Drug Firm for $21B

Abbvie Buys Cancer Drug Firm for $21B

Bloomberg.comDrew Armstrong and Ed

AbbVie Stock

Abbvie CEO on Allergan acquisition, Covid-19's effect on demand and more

Abbvie CEO on Allergan acquisition, Covid-19's effect on demand and more

CNBCJordan Smith

Final Trades: Abbvie, Broadcom, Deere

Final Trades: Abbvie, Broadcom, Deere

AbbVie Has A New Cash Cow As Humira Bows To Skyrizi

AbbVie Has A New Cash Cow As Humira Bows To Skyrizi